313 related articles for article (PubMed ID: 18374723)
21. [Multidetector CT and MRI of benign liver tumors].
Van Beers B; Horsmans Y; Sempoux C
J Radiol; 2003 Apr; 84(4 Pt 2):445-56; discussion 457-8. PubMed ID: 12844065
[TBL] [Abstract][Full Text] [Related]
22. [MR diagnosis of focal liver lesions].
Palkó A
Orv Hetil; 2004 Feb; 145(7 Suppl 1):374-7. PubMed ID: 15049054
[TBL] [Abstract][Full Text] [Related]
23. [Magnetic resonance imaging of the liver: what kind of contrast agents?].
De Gaspari A; De Cobelli F; Del Maschio A
Radiol Med; 2001 Sep; 102(3):109-21. PubMed ID: 11677451
[TBL] [Abstract][Full Text] [Related]
24. Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis.
Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
Clin Imaging; 2008; 32(6):453-9. PubMed ID: 19006774
[TBL] [Abstract][Full Text] [Related]
25. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
[TBL] [Abstract][Full Text] [Related]
26. MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison.
Fröhlich JM
J Magn Reson Imaging; 2004 Mar; 19(3):375-6; author reply 376. PubMed ID: 14994308
[No Abstract] [Full Text] [Related]
27. The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
Burke C; Alexander Grant L; Goh V; Griffin N
Semin Ultrasound CT MR; 2013 Feb; 34(1):44-53. PubMed ID: 23395317
[TBL] [Abstract][Full Text] [Related]
28. Confluent focal nodular hyperplasia mimicking liver cancer: value of liver-specific contrast-enhanced MRI for diagnosis.
Cheng YC; Chiang CM; Wu CC; Chai JW
J Chin Med Assoc; 2012 Jul; 75(7):355-8. PubMed ID: 22824052
[TBL] [Abstract][Full Text] [Related]
29. MR imaging of CNS tumors: are all contrast agents created the same?
Essig M
Neuroradiology; 2006 Apr; 48 Suppl 1():3-8. PubMed ID: 16699847
[TBL] [Abstract][Full Text] [Related]
30. Focal nodular hyperplasia in children following treatment of hemato-oncologic diseases.
Freidl T; Lackner H; Huber J; Sovinz P; Moser A; Schroettner B; Schwinger W; Urban C
Klin Padiatr; 2008; 220(6):384-7. PubMed ID: 18949676
[TBL] [Abstract][Full Text] [Related]
31. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
[TBL] [Abstract][Full Text] [Related]
32. Pediatric liver: focal masses.
Siegel MJ; Chung EM; Conran RM
Magn Reson Imaging Clin N Am; 2008 Aug; 16(3):437-52, v. PubMed ID: 18585597
[TBL] [Abstract][Full Text] [Related]
33. [Focal nodular hyperplasia of liver].
Luk'ianchenko AB; Medvedeva BM; Shabanov MA; Luk'ianchenko KA
Vestn Rentgenol Radiol; 2013; (3):61-8. PubMed ID: 25669079
[No Abstract] [Full Text] [Related]
34. Nodular regenerative hyperplasia and focal nodular hyperplasia of the liver mimicking hepatic metastasis in children with solid tumors and a review of literature.
Citak EC; Karadeniz C; Oguz A; Boyunaga O; Ekinci O; Okur V
Pediatr Hematol Oncol; 2007 Jun; 24(4):281-9. PubMed ID: 17613871
[TBL] [Abstract][Full Text] [Related]
35. MRI features of inflammatory hepatocellular adenomas on hepatocyte phase imaging with liver-specific contrast agents.
Thomeer MG; Willemssen FE; Biermann KK; El Addouli H; de Man RA; Ijzermans JN; Dwarkasing RS
J Magn Reson Imaging; 2014 May; 39(5):1259-64. PubMed ID: 23897798
[TBL] [Abstract][Full Text] [Related]
36. Imaging of paediatric liver tumours with pathological correlation.
Das CJ; Dhingra S; Gupta AK; Iyer V; Agarwala S
Clin Radiol; 2009 Oct; 64(10):1015-25. PubMed ID: 19748008
[TBL] [Abstract][Full Text] [Related]
37. Review article: the evaluation of solitary liver masses.
Bahirwani R; Reddy KR
Aliment Pharmacol Ther; 2008 Oct; 28(8):953-65. PubMed ID: 18643922
[TBL] [Abstract][Full Text] [Related]
38. Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers.
Brismar TB; Dahlstrom N; Edsborg N; Persson A; Smedby O; Albiin N
Acta Radiol; 2009 Sep; 50(7):709-15. PubMed ID: 19701821
[TBL] [Abstract][Full Text] [Related]
39. [Focal nodular hyperplasia of the liver: benign lesion with often surgical treatment. Magnetic resonance and laparoscopic findings].
Pons V; Ramirez JJ; Nos P; Carrasco D; Juan M; Berenguer J
Gastroenterol Hepatol; 1995; 18(7):379-83. PubMed ID: 7553276
[TBL] [Abstract][Full Text] [Related]
40. [1,5 Tesla MRI in focal nodular hyperplasia. Review of the literature apropos of 7 cases].
Padovani B; Marie JF; Sedat J; Chanalet S; Bidoli D; Saint-Paul MC; Serres JJ; Bruneton JN
J Radiol; 1994 Feb; 75(2):111-6. PubMed ID: 8151551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
